Effects of Low Dose Pioglitazone on Restenosis and Coronary Atherosclerosis in Diabetic Patients Undergoing Drug Eluting Stent Implantation-Reference-Cited by-同舟云学术

Effects of Low Dose Pioglitazone on Restenosis and Coronary Atherosclerosis in Diabetic Patients Undergoing Drug Eluting Stent Implantation

Published:2013 Issue:6 Volume:54 Page:1313
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Lee Hye Won¹,Lee Han Cheol¹,Kim Bo Won¹,Yang Mi Jin¹,Park Jin Sup¹,Oh Jun Hyok¹,Choi Jung Hyun¹,Cha Kwang Soo¹,Hong Taek Jong¹,Kim Sang-Pil¹,Song Seunghwan¹,Park Jong-Ha¹

Affiliation:

1. Division of Cardiology, Department of Internal Medicine, College of Medicine, Pusan National University, Medical Research Institute, Pusan National University Hospital, Busan, Korea.

Funder

Ministry of Health and Welfare

Publisher

Yonsei University College of Medicine

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3349/ymj.2013.54.6.1313

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials;Nutrition, Metabolism and Cardiovascular Diseases;2021-12

2. Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug;Cardiovascular Diabetology;2021-05-18

3. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials;BMJ;2021-01-13

4. Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials;Scientific Reports;2020-09-25

5. Pioglitazone for the Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis;The Journal of Clinical Endocrinology & Metabolism;2019-12-10